CN102204679A - 一种四联菌片及其制备方法 - Google Patents
一种四联菌片及其制备方法 Download PDFInfo
- Publication number
- CN102204679A CN102204679A CN2011101613521A CN201110161352A CN102204679A CN 102204679 A CN102204679 A CN 102204679A CN 2011101613521 A CN2011101613521 A CN 2011101613521A CN 201110161352 A CN201110161352 A CN 201110161352A CN 102204679 A CN102204679 A CN 102204679A
- Authority
- CN
- China
- Prior art keywords
- bacterium
- tetrad
- sheet
- preparation
- bacterium sheet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 30
- 230000001580 bacterial effect Effects 0.000 title abstract description 33
- 239000000843 powder Substances 0.000 claims abstract description 41
- 240000001046 Lactobacillus acidophilus Species 0.000 claims abstract description 31
- 241001608472 Bifidobacterium longum Species 0.000 claims abstract description 30
- 241000194020 Streptococcus thermophilus Species 0.000 claims abstract description 27
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims abstract description 24
- 229940009291 bifidobacterium longum Drugs 0.000 claims abstract description 24
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims abstract description 24
- 244000199866 Lactobacillus casei Species 0.000 claims abstract description 22
- 239000000463 material Substances 0.000 claims abstract description 19
- 235000013958 Lactobacillus casei Nutrition 0.000 claims abstract description 16
- 229940017800 lactobacillus casei Drugs 0.000 claims abstract description 16
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims abstract description 12
- 150000003271 galactooligosaccharides Chemical class 0.000 claims abstract description 12
- 241000894006 Bacteria Species 0.000 claims description 96
- 238000002156 mixing Methods 0.000 claims description 35
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 34
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 28
- 238000004321 preservation Methods 0.000 claims description 23
- 239000000203 mixture Substances 0.000 claims description 22
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 12
- 239000008103 glucose Substances 0.000 claims description 12
- 238000012856 packing Methods 0.000 claims description 12
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 11
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 11
- 239000005913 Maltodextrin Substances 0.000 claims description 9
- 229920002774 Maltodextrin Polymers 0.000 claims description 9
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 9
- 239000002253 acid Substances 0.000 claims description 9
- 229940035034 maltodextrin Drugs 0.000 claims description 9
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 9
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 9
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 9
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 8
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 8
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 8
- 244000005700 microbiome Species 0.000 claims description 8
- 230000001070 adhesive effect Effects 0.000 claims description 5
- 239000000853 adhesive Substances 0.000 claims description 4
- 235000003599 food sweetener Nutrition 0.000 claims description 3
- 239000003765 sweetening agent Substances 0.000 claims description 3
- 241000186000 Bifidobacterium Species 0.000 abstract description 11
- 239000006041 probiotic Substances 0.000 abstract description 10
- 235000018291 probiotics Nutrition 0.000 abstract description 10
- 235000013305 food Nutrition 0.000 abstract description 5
- 241000186660 Lactobacillus Species 0.000 abstract description 4
- 229940039696 lactobacillus Drugs 0.000 abstract description 4
- 235000013406 prebiotics Nutrition 0.000 abstract description 2
- 230000009286 beneficial effect Effects 0.000 abstract 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 abstract 1
- 230000000529 probiotic effect Effects 0.000 abstract 1
- 235000019589 hardness Nutrition 0.000 description 30
- 239000000047 product Substances 0.000 description 29
- 239000012530 fluid Substances 0.000 description 24
- 239000007788 liquid Substances 0.000 description 17
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 16
- 230000004083 survival effect Effects 0.000 description 14
- 239000001963 growth medium Substances 0.000 description 13
- 238000000926 separation method Methods 0.000 description 13
- 238000009777 vacuum freeze-drying Methods 0.000 description 13
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 12
- 239000000523 sample Substances 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 239000002609 medium Substances 0.000 description 11
- 238000000034 method Methods 0.000 description 11
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 10
- 239000006228 supernatant Substances 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 235000015278 beef Nutrition 0.000 description 8
- 239000008101 lactose Substances 0.000 description 8
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 8
- 235000019341 magnesium sulphate Nutrition 0.000 description 8
- 238000000746 purification Methods 0.000 description 8
- 238000012216 screening Methods 0.000 description 8
- 230000001954 sterilising effect Effects 0.000 description 8
- 238000004659 sterilization and disinfection Methods 0.000 description 8
- 238000003805 vibration mixing Methods 0.000 description 8
- 239000000284 extract Substances 0.000 description 7
- 230000002496 gastric effect Effects 0.000 description 7
- 238000011081 inoculation Methods 0.000 description 7
- 239000002245 particle Substances 0.000 description 7
- 239000003223 protective agent Substances 0.000 description 7
- 239000001888 Peptone Substances 0.000 description 6
- 108010080698 Peptones Proteins 0.000 description 6
- 210000000941 bile Anatomy 0.000 description 6
- 229940099352 cholate Drugs 0.000 description 6
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 6
- 238000010790 dilution Methods 0.000 description 6
- 239000012895 dilution Substances 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000000855 fermentation Methods 0.000 description 6
- 230000004151 fermentation Effects 0.000 description 6
- 230000000968 intestinal effect Effects 0.000 description 6
- 239000004310 lactic acid Substances 0.000 description 6
- 235000014655 lactic acid Nutrition 0.000 description 6
- 235000019319 peptone Nutrition 0.000 description 6
- 238000010298 pulverizing process Methods 0.000 description 6
- 238000012797 qualification Methods 0.000 description 6
- 235000020183 skimmed milk Nutrition 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 230000003203 everyday effect Effects 0.000 description 5
- 239000002054 inoculum Substances 0.000 description 5
- 238000000386 microscopy Methods 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 235000021262 sour milk Nutrition 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical compound CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 4
- 235000019796 monopotassium phosphate Nutrition 0.000 description 4
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 4
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 4
- 229920000053 polysorbate 80 Polymers 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 3
- 229930182816 L-glutamine Natural products 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 235000013365 dairy product Nutrition 0.000 description 3
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- 238000000227 grinding Methods 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 235000013923 monosodium glutamate Nutrition 0.000 description 3
- 230000000877 morphologic effect Effects 0.000 description 3
- 230000035479 physiological effects, processes and functions Effects 0.000 description 3
- 238000011218 seed culture Methods 0.000 description 3
- 229940073490 sodium glutamate Drugs 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- 108020004465 16S ribosomal RNA Proteins 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 102000016938 Catalase Human genes 0.000 description 2
- 108010053835 Catalase Proteins 0.000 description 2
- 241001478240 Coccus Species 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 239000004201 L-cysteine Substances 0.000 description 2
- 235000013878 L-cysteine Nutrition 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- VLSOAXRVHARBEQ-UHFFFAOYSA-N [4-fluoro-2-(hydroxymethyl)phenyl]methanol Chemical compound OCC1=CC=C(F)C=C1CO VLSOAXRVHARBEQ-UHFFFAOYSA-N 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 102000005936 beta-Galactosidase Human genes 0.000 description 2
- 108010005774 beta-Galactosidase Proteins 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000001055 chewing effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- -1 citric acid diamines Chemical class 0.000 description 2
- 229960002433 cysteine Drugs 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 2
- 229910000397 disodium phosphate Inorganic materials 0.000 description 2
- 235000019800 disodium phosphate Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000003891 ferrous sulphate Nutrition 0.000 description 2
- 239000011790 ferrous sulphate Substances 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 2
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 2
- 235000015138 kumis Nutrition 0.000 description 2
- 229940099596 manganese sulfate Drugs 0.000 description 2
- 235000007079 manganese sulphate Nutrition 0.000 description 2
- 239000011702 manganese sulphate Substances 0.000 description 2
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000009702 powder compression Methods 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000002797 proteolythic effect Effects 0.000 description 2
- 108010009004 proteose-peptone Proteins 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- 201000004384 Alopecia Diseases 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000186016 Bifidobacterium bifidum Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- XINCECQTMHSORG-UHFFFAOYSA-N Isoamyl isovalerate Chemical compound CC(C)CCOC(=O)CC(C)C XINCECQTMHSORG-UHFFFAOYSA-N 0.000 description 1
- 201000010538 Lactose Intolerance Diseases 0.000 description 1
- 241000321422 Mycteroperca jordani Species 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 229940002008 bifidobacterium bifidum Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000007621 cluster analysis Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012520 frozen sample Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005550 wet granulation Methods 0.000 description 1
- 235000020985 whole grains Nutrition 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011101613521A CN102204679B (zh) | 2011-06-16 | 2011-06-16 | 一种四联菌片及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011101613521A CN102204679B (zh) | 2011-06-16 | 2011-06-16 | 一种四联菌片及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102204679A true CN102204679A (zh) | 2011-10-05 |
CN102204679B CN102204679B (zh) | 2013-01-30 |
Family
ID=44693954
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011101613521A Active CN102204679B (zh) | 2011-06-16 | 2011-06-16 | 一种四联菌片及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102204679B (zh) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104122348A (zh) * | 2014-08-06 | 2014-10-29 | 山东蓝星东大化工有限责任公司 | 顶空气相色谱分析外标法定量用大粘度标准溶液配制方法 |
CN104366486A (zh) * | 2014-12-10 | 2015-02-25 | 孙伟 | 五联益生菌咀嚼片的配方及制备方法 |
CN104522648A (zh) * | 2014-12-18 | 2015-04-22 | 杭州龙达新科生物制药有限公司 | 一种四联益生菌制剂及应用 |
CN104783289A (zh) * | 2015-03-25 | 2015-07-22 | 孙伟 | γ-氨基丁酸五联益生菌固体饮料的配方及制备方法 |
CN106616602A (zh) * | 2016-12-09 | 2017-05-10 | 宁夏沃福百瑞枸杞产业股份有限公司 | 一种黑枸杞益生菌片的制备方法 |
CN106690327A (zh) * | 2016-11-30 | 2017-05-24 | 北京科拓恒通生物技术开发有限公司 | 一种混合益生菌片剂及其低温包衣制备方法 |
CN107772477A (zh) * | 2017-11-27 | 2018-03-09 | 内蒙古普泽生物制品有限责任公司 | 一种富含硒的复合益生菌粉制剂及其制备方法 |
CN109999059A (zh) * | 2019-04-18 | 2019-07-12 | 内蒙古普泽生物制品有限责任公司 | 一种妇科微生态抑菌制剂及其应用 |
CN110960560A (zh) * | 2019-12-09 | 2020-04-07 | 上海交大昂立股份有限公司 | 一种高益生菌活性的片剂及其制备方法和应用 |
CN112210511A (zh) * | 2020-10-10 | 2021-01-12 | 内蒙古普泽生物制品有限责任公司 | 一种具有抑制ht-29细胞增殖及益生功能的长双歧杆菌及应用 |
CN112538440A (zh) * | 2020-10-12 | 2021-03-23 | 内蒙古普泽生物制品有限责任公司 | 一种复合益生菌制剂及其制备方法和在促进人体乙醇代谢中的应用 |
CN113025513A (zh) * | 2019-12-25 | 2021-06-25 | 生合生物科技(扬州)有限公司 | 一种可用于预防皮肤炎症的活性益生菌爽身粉及其制法 |
CN113116939A (zh) * | 2019-12-31 | 2021-07-16 | 杭州远大生物制药有限公司 | 微生物制剂及其制备方法 |
US11541082B2 (en) | 2017-06-05 | 2023-01-03 | Probi Ab | Microbial compositions |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1185904A (zh) * | 1996-12-23 | 1998-07-01 | 思简-约莫公司 | 含冻干的活乳酸菌的食用组合物 |
CN1121864C (zh) * | 2000-07-06 | 2003-09-24 | 吉林省威特集团生化药业有限责任公司 | 双歧四联活菌片 |
CN101541194A (zh) * | 2006-09-27 | 2009-09-23 | 利特尔卡鲁梅控股有限公司 | 口服益生菌剂型 |
CN101724623A (zh) * | 2009-12-14 | 2010-06-09 | 内蒙古农业大学 | 干酪乳杆菌Zhang微胶囊及其制备方法与它们的用途 |
-
2011
- 2011-06-16 CN CN2011101613521A patent/CN102204679B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1185904A (zh) * | 1996-12-23 | 1998-07-01 | 思简-约莫公司 | 含冻干的活乳酸菌的食用组合物 |
CN1121864C (zh) * | 2000-07-06 | 2003-09-24 | 吉林省威特集团生化药业有限责任公司 | 双歧四联活菌片 |
CN101541194A (zh) * | 2006-09-27 | 2009-09-23 | 利特尔卡鲁梅控股有限公司 | 口服益生菌剂型 |
CN101724623A (zh) * | 2009-12-14 | 2010-06-09 | 内蒙古农业大学 | 干酪乳杆菌Zhang微胶囊及其制备方法与它们的用途 |
Non-Patent Citations (2)
Title |
---|
《畜牧与饲料科学》 20051231 韩勇军等 益生素的免疫增强作用 第5-6页 1 , 第6期 * |
《药剂学》 20080131 林宁等 粉末直接压片法 湖北长江出版集团 第162-163页 8 , * |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104122348A (zh) * | 2014-08-06 | 2014-10-29 | 山东蓝星东大化工有限责任公司 | 顶空气相色谱分析外标法定量用大粘度标准溶液配制方法 |
CN104366486A (zh) * | 2014-12-10 | 2015-02-25 | 孙伟 | 五联益生菌咀嚼片的配方及制备方法 |
CN104522648A (zh) * | 2014-12-18 | 2015-04-22 | 杭州龙达新科生物制药有限公司 | 一种四联益生菌制剂及应用 |
CN104783289A (zh) * | 2015-03-25 | 2015-07-22 | 孙伟 | γ-氨基丁酸五联益生菌固体饮料的配方及制备方法 |
CN106690327A (zh) * | 2016-11-30 | 2017-05-24 | 北京科拓恒通生物技术开发有限公司 | 一种混合益生菌片剂及其低温包衣制备方法 |
CN106616602A (zh) * | 2016-12-09 | 2017-05-10 | 宁夏沃福百瑞枸杞产业股份有限公司 | 一种黑枸杞益生菌片的制备方法 |
US11541082B2 (en) | 2017-06-05 | 2023-01-03 | Probi Ab | Microbial compositions |
CN107772477A (zh) * | 2017-11-27 | 2018-03-09 | 内蒙古普泽生物制品有限责任公司 | 一种富含硒的复合益生菌粉制剂及其制备方法 |
CN109999059A (zh) * | 2019-04-18 | 2019-07-12 | 内蒙古普泽生物制品有限责任公司 | 一种妇科微生态抑菌制剂及其应用 |
CN110960560A (zh) * | 2019-12-09 | 2020-04-07 | 上海交大昂立股份有限公司 | 一种高益生菌活性的片剂及其制备方法和应用 |
CN113025513A (zh) * | 2019-12-25 | 2021-06-25 | 生合生物科技(扬州)有限公司 | 一种可用于预防皮肤炎症的活性益生菌爽身粉及其制法 |
CN113116939A (zh) * | 2019-12-31 | 2021-07-16 | 杭州远大生物制药有限公司 | 微生物制剂及其制备方法 |
CN112210511A (zh) * | 2020-10-10 | 2021-01-12 | 内蒙古普泽生物制品有限责任公司 | 一种具有抑制ht-29细胞增殖及益生功能的长双歧杆菌及应用 |
CN112538440A (zh) * | 2020-10-12 | 2021-03-23 | 内蒙古普泽生物制品有限责任公司 | 一种复合益生菌制剂及其制备方法和在促进人体乙醇代谢中的应用 |
CN112538440B (zh) * | 2020-10-12 | 2023-03-17 | 内蒙古普泽生物制品有限责任公司 | 一种复合益生菌制剂及其制备方法和在促进人体乙醇代谢中的应用 |
Also Published As
Publication number | Publication date |
---|---|
CN102204679B (zh) | 2013-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102204679B (zh) | 一种四联菌片及其制备方法 | |
Rajoka et al. | Identification, characterization, and probiotic potential of Lactobacillus rhamnosus isolated from human milk | |
CN102089422B (zh) | 新的益生长双歧杆菌 | |
CN101338283B (zh) | 一种干酪乳杆菌及其在固态发酵中的应用 | |
CN108004189A (zh) | 一种复合益生乳酸菌粉剂及其制备方法与应用 | |
CN102242184B (zh) | 一种四联菌片的菌种的活菌数检测方法 | |
CN101333505B (zh) | 一种干酪乳杆菌在抗氧化作用方面的应用 | |
US9649347B2 (en) | Protective effects and application of a Lactobacillus rhamnosus on the alleviation of chronic alcoholic liver injury | |
CN104928208B (zh) | 一种植物乳杆菌Lp90及其筛选方法和应用 | |
CN110106119B (zh) | 一株分离自母乳的鼠李糖乳杆菌m9及其应用 | |
CN106834187A (zh) | 一种两歧双歧杆菌及其用途 | |
CN104489646A (zh) | 一种果蔬益生菌片剂及其制备方法 | |
CN109957530A (zh) | 一种植物乳杆菌及其应用 | |
CN103766486B (zh) | 一种含有双歧杆菌包埋珠的乳饮料及其制备方法 | |
CN101139557A (zh) | 一种干酪乳杆菌及其在改善血脂代谢和免疫调节中的应用 | |
US20220218769A1 (en) | Strain of Lactobacillus crispatus Capable of Preventing and/or Treating Helicobacter pylori Infection | |
CN113061543A (zh) | 一种植物乳杆菌及其用途 | |
CN107287133A (zh) | 一株植物乳杆菌lly‑606及其应用 | |
CN105420150A (zh) | 一种嗜酸乳杆菌及其应用 | |
TWI785815B (zh) | 用於促進益生菌生長的方法 | |
CN107227275A (zh) | 一种发酵乳杆菌hy01及其用途 | |
CN104328076A (zh) | 一种产胆盐水解酶副干酪乳杆菌益生菌片的制备方法 | |
TW202200029A (zh) | 可促進排便的組合物及其用途 | |
CN106307549A (zh) | 灭活型乳酸菌微生态制剂及其制备方法和应用 | |
CN112218646A (zh) | 一种组合物及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: INNER MONGOLIA PUZE BIOLOGICAL PRODUCTS CO., LTD. Free format text: FORMER OWNER: GAO JIE Effective date: 20121126 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20121126 Address after: 010080 Inner Mongolia Hohhot City Industrial Park, Jinchuan Development Zone West Gold seven road and Fenglin Road Interchange Applicant after: INNER MONGOLIA PUZE BIOLOGICS CO.,LTD. Address before: 010080 the Inner Mongolia Autonomous Region Hohhot City Industrial Park, Jinchuan Development Zone West Gold seven road and Fenglin Road Interchange Project of Inner Mongolia Biological Products Co. Ltd. Applicant before: Gao Jie |
|
ASS | Succession or assignment of patent right |
Owner name: THE LIGHT INDUSTRY RESEARCH INSTITUTE OF INNER MON Effective date: 20121206 Owner name: INNER MONGOLIA PUZE BIOLOGICAL PRODUCTS CO., LTD. Free format text: FORMER OWNER: GAO JIE Effective date: 20121206 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20121206 Address after: 010080 Inner Mongolia Hohhot City Industrial Park, Jinchuan Development Zone West Gold seven road and Fenglin Road Interchange Applicant after: INNER MONGOLIA PUZE BIOLOGICS CO.,LTD. Applicant after: Inner Mongolia Light Industry Science Research Institute Co.,Ltd. Applicant after: NEIMENGGU BEIXING BIOTECHNOLOGY Co.,Ltd. Address before: 010080 Inner Mongolia Hohhot City Industrial Park, Jinchuan Development Zone West Gold seven road and Fenglin Road Interchange Project of Inner Mongolia Biological Products Co. Ltd. Applicant before: Gao Jie |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 010080 intersection of Jinqi road and Fenglin Road, West District, industrial park, Jinchuan Development Zone, Hohhot, Inner Mongolia Autonomous Region Patentee after: INNER MONGOLIA PUZE BIOLOGICS CO.,LTD. Patentee after: Inner Mongolia Light Industry Science Research Institute Co.,Ltd. Patentee after: INNER MONGOLIA BEIXING BIOTECHNOLOGY Co.,Ltd. Address before: 010080 intersection of Jinqi road and Fenglin Road, West District, industrial park, Jinchuan Development Zone, Hohhot, Inner Mongolia Patentee before: INNER MONGOLIA PUZE BIOLOGICS CO.,LTD. Patentee before: Inner Mongolia Light Industry Science Research Institute Co.,Ltd. Patentee before: NEIMENGGU BEIXING BIOTECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20220127 Address after: 010080 intersection of Jinqi road and Fenglin Road, West District, industrial park, Jinchuan Development Zone, Hohhot, Inner Mongolia Patentee after: INNER MONGOLIA PUZE BIOLOGICS CO.,LTD. Address before: 010080 intersection of Jinqi road and Fenglin Road, West District, industrial park, Jinchuan Development Zone, Hohhot, Inner Mongolia Autonomous Region Patentee before: INNER MONGOLIA PUZE BIOLOGICS CO.,LTD. Patentee before: Inner Mongolia Light Industry Science Research Institute Co.,Ltd. Patentee before: INNER MONGOLIA BEIXING BIOTECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right |